Logo

American Heart Association

  29
  0


Final ID:

Discussant: MAPLE-HCM Responder Analysis

  • Hegde, Sheila  ( University of Texas Southwestern Medical Center , Dallas , Texas , United States )
  • Saberi, Sara  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Author Disclosures:
    Sheila Hegde: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Cytokinetics:Active (exists now) ; Advisor:Cytokinetics:Past (completed) ; Other (please indicate in the box next to the company name):Bristol Myers Squibb:Active (exists now) | Sara Saberi: DO have relevant financial relationships ; Consultant:Cytokinetics, Inc:Active (exists now) ; Research Funding (PI or named investigator):Edgewise:Expected (by end of conference) ; Research Funding (PI or named investigator):Novartis:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics, Inc:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

From Madrid to Mardi Gras: Heart Failure Trials on Parade

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Efficacy and safety of Digitoxin in heart failure with reduced ejection fraction according to age: Insights from DIGIT-HF

Bavendiek Udo, Huelsmann Martin, Von Der Leyen Heiko, Veltmann Christian, Stork Stefan, Boehm Michael, Koch Armin, Bauersachs Johann, Berliner Dominik, Thomas Nele, Grosshennig Anika, Schwab Johannes, Rieth Andreas, Maier Lars, Gaspar Thomas, Zdravkovic Marija

How will RCTs change guidelines and clinical practice

Heidenreich Paul

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available